GlassScriptPhysician profile
William L Cauthen
NPI 1417186347
$16,724.77
in general payments reported to CMS, 2019-2025
22 companies · $862 in 2025
The $862 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,409 · 2020: $69.45 · 2021: $300 · 2022: $545 · 2023: $3,551 · 2024: $9,989 · 2025: $862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,750 · Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,750.00 |
| Food and Beverage | $1,152.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,186.59 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $312.30 | 2021-2025 | Closurefast, Sonicision, Venaseal |
| Allergan, INC. | $177.57 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $163.91 | 2019-2022 | |
| Covidien LP | $149.00 | 2019 | |
| Ethicon US, LLC | $147.89 | 2019-2022 | |
| Tetraphase Pharmaceuticals, INC. | $128.80 | 2019 | |
| Access Pro Medical, LLC | $78.29 | 2023 | Matriderm |
| Kerecis Limited | $68.50 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Cumberland Pharmaceuticals, INC. | $57.58 | 2022 | |
| Hologic Sales and Service, LLC | $31.64 | 2022-2024 | Coolseal Generator |
| Conmed Corporation | $27.27 | 2019 | |
| Dilon Technologies, INC. | $26.59 | 2025 | Hemoblast Bellows |
| Innovation Technologies INC | $26.12 | 2024 | Irrisept |
| Integra Lifesciences Corporation | $22.54 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22.42 | 2020 | |
| Smith+Nephew, INC. | $21.38 | 2023 | Renasys Go V2 Home |
| Baxter Healthcare | $19.97 | 2019 | |
| Tela Bio, INC. | $17.43 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Merck Sharp & Dohme LLC | $15.00 | 2019 | |
| Novo Nordisk INC | $12.00 | 2022 | |
| Tei Biosciences INC | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cauthen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.